Similarly, IDO inhibition in mouse models of metastatic liver, bladder and lung cancers caused an increased TIL proliferation and reduced Treg infiltrate in the TME, which were associated with delayed tumour growth [354,355,356]. Here, IDO1 is linked to lung cancer.